Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
26 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/26/2954102/0/en/Grant-of-Restricted-Stock-Units-and-Warrants-to-Employees-in-Genmab.html
15 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/15/2946292/0/en/Investigational-Rinatabart-Sesutecan-Rina-S-Shows-Promising-Anti-Tumor-Activity-as-Single-Agent-in-Heavily-Pretreated-Patients-with-Ovarian-and-Endometrial-Cancers-in-Phase-1-2-Cli.html
10 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/10/2944125/0/en/Capital-Increase-in-Genmab-as-a-Result-of-Employee-Warrant-Exercise.html
26 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/26/2935725/0/en/Genmab-to-Present-at-Morgan-Stanley-22nd-Annual-Global-Healthcare-Conference.html
19 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/19/2932382/0/en/TEPKINLY-epcoritamab-Receives-Second-European-Commission-Approval-for-the-Treatment-of-Adults-with-Relapsed-Refractory-Follicular-Lymphoma.html
19 Aug 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/genmab-shuffles-c-suite-commercialization-manufacturing-portfolio-grows
ABOUT THIS PAGE
Genmab is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of HUMAN MONOCLONAL ANTIBODY TO CD4 (ZANOLIMUNAB) bulk offered by Genmab
LOOKING FOR A SUPPLIER?